{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T21:57:20Z","timestamp":1784584640500,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study aimed to investigate the expression level of the GATA6 gene in different oral cancer cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, we sub-cultured normal oral epithelial cell lines HOK, human tongue squamous cell carcinoma cell lines CAL-27 and SCC-4, and human salivary gland adenoid cystic carcinoma cell lines SACC-LM and SACC-83. Subsequently, we used reverse transcription-polymerase chain reaction RT-PCR and Western blot methods to detect the mRNA and the protein expressions of GATA6 in normal oral epithelial cells, human tongue squamous cell carcinoma cells, and human salivary gland adenoid cystic carcinoma cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The results of this study showed that the mRNA expression levels of GATA6 in CAL-27, SCC-4, and SACC-LM cells were significantly increased when compared with the HOK cells. However, the mRNA expression level of GATA6 in the SACC-83 cells had no significant difference compared with the HOK cells. The protein expression levels of GATA6 in the SCC-4 and SACC-LM cells were, however, significantly increased whereas the protein expression levels of GATA6 in the CAL-27 and SACC-83 cells had no significant difference when compared with the HOK cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The GATA6 gene may be related to the occurrence and progression of certain oral cancers.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-021-02245-y","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T22:02:45Z","timestamp":1621375365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The expression of the GATA6 gene in oral carcinoma cell lines"],"prefix":"10.1186","volume":"19","author":[{"given":"Cheng-Lin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9270-9751","authenticated-orcid":false,"given":"Wei-Qun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"issue":"9","key":"2245_CR1","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/sj.bdj.2017.380","volume":"222","author":"P Varela-Centelles","year":"2017","unstructured":"Varela-Centelles P, Castelo-Baz P, Seoane-Romero J. Oral cancer: Early\/delayed diagnosis. Br Dent J. 2017;222(9):643. https:\/\/doi.org\/10.1038\/sj.bdj.2017.380.","journal-title":"Br Dent J."},{"issue":"10","key":"2245_CR2","first-page":"645","volume":"156","author":"Y Ghantous","year":"2017","unstructured":"Ghantous Y, Abu EI. Global incidence and risk factors of oral cancer. Harefuah. 2017;156(10):645\u20139.","journal-title":"Harefuah."},{"key":"2245_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cellsig.2017.10.009","volume":"42","author":"F Momen-Heravi","year":"2018","unstructured":"Momen-Heravi F, Bala S. Emerging role of non-coding RNA in oral cancer. Cell Signal. 2018;42:134\u201343. https:\/\/doi.org\/10.1016\/j.cellsig.2017.10.009.","journal-title":"Cell Signal."},{"issue":"6","key":"2245_CR4","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.oooo.2016.08.021","volume":"123","author":"PM Speight","year":"2017","unstructured":"Speight PM, Epstein J, Kujan O, Lingen MW, Nagao T, Ranganathan K, et al. Screening for oral cancer-a perspective from the Global Oral Cancer Forum. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;123(6):680\u20137. https:\/\/doi.org\/10.1016\/j.oooo.2016.08.021.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol."},{"issue":"3","key":"2245_CR5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/gutjnl-2014-308042","volume":"65","author":"P Martinelli","year":"2016","unstructured":"Martinelli P, Madriles F, Ca\u00f1amero M, Pau ECDS, Pozo N, Guerra C, et al. The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice. Gut. 2016;65(3):476\u201386. https:\/\/doi.org\/10.1136\/gutjnl-2014-308042.","journal-title":"Gut."},{"issue":"7","key":"2245_CR6","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1242\/bio.026120","volume":"6","author":"JB Fisher","year":"2017","unstructured":"Fisher JB, Pulakanti K, Rao S, Duncan SA. GATA6 is essential for endoderm formation from human pluripotent stem cells. Biol Open. 2017;6(7):1084\u201395. https:\/\/doi.org\/10.1242\/bio.026120.","journal-title":"Biol Open."},{"issue":"17","key":"2245_CR7","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.2217\/fon-2018-0064","volume":"14","author":"X Zhao","year":"2018","unstructured":"Zhao X, Zhang W, Ji W. miR-181a targets GATA6 to inhibit the progression of human laryngeal squamous cell carcinoma. Future Oncol. 2018;14(17):1741\u201353. https:\/\/doi.org\/10.2217\/fon-2018-0064.","journal-title":"Future Oncol."},{"key":"2245_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12885-017-3166-z","volume":"17","author":"F Tian","year":"2017","unstructured":"Tian F, Chen J, Zheng S, et al. miR-124 targets GATA6 to suppress cholangiocarcinoma cell invasion and metastasis. BMC Cancer. 2017;17:175.","journal-title":"BMC Cancer"},{"issue":"12","key":"2245_CR9","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.15252\/emmm.201606382","volume":"8","author":"A Mehta","year":"2016","unstructured":"Mehta A, Cordero J, Dobersch S, Romero-Olmedo AJ, Savai R, Bodner J, et al. Non-invasive lung cancer diagnosis by detection of GATA6 and NKX2-1 isoforms in exhaled breath condensate. EMBO Mol Med. 2016;8(12):1380\u20139. https:\/\/doi.org\/10.15252\/emmm.201606382.","journal-title":"EMBO Mol Med."},{"issue":"17","key":"2245_CR10","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1128\/MCB.00087-09","volume":"29","author":"CD Capo-chichi","year":"2009","unstructured":"Capo-chichi CD, Cai KQ, Testa JR, Godwin AK, Xu XX. Loss of GATA6 leads to nuclear deformation and aneuploidy in ovarian cancer. Mol Cell Biol. 2009;29(17):4766\u201377. https:\/\/doi.org\/10.1128\/MCB.00087-09.","journal-title":"Mol Cell Biol."},{"issue":"19","key":"2245_CR11","doi-asserted-by":"publisher","first-page":"8053","DOI":"10.1073\/pnas.0611669104","volume":"104","author":"D Kamnasaran","year":"2007","unstructured":"Kamnasaran D, Qian B, Hawkins C, Stanford WL, Guha A. GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model. Proc Natl Acad Sci U S A. 2007;104(19):8053\u20138. https:\/\/doi.org\/10.1073\/pnas.0611669104.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"9","key":"2245_CR12","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1002\/ijc.22092","volume":"119","author":"M Guo","year":"2006","unstructured":"Guo M, MG H, Akiyama Y, et al. Hypermethylation of the GATA gene family in esophageal cancer. Int J Cancer. 2006;119(9):2078\u201383. https:\/\/doi.org\/10.1002\/ijc.22092.","journal-title":"Int J Cancer."},{"issue":"8","key":"2245_CR13","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1073\/pnas.1917531117","volume":"117","author":"G Liang","year":"2020","unstructured":"Liang G, Meng W, Huang X, Zhu W, Yin C, Wang C, et al. miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer. Proc Natl Acad Sci U S A. 2020;117(8):4347\u201357. https:\/\/doi.org\/10.1073\/pnas.1917531117.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"2245_CR14","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.18632\/oncotarget.13580","volume":"8","author":"S Fantini","year":"2017","unstructured":"Fantini S, Salsi V, Reggiani L, Maiorana A, Zappavigna V. The miR-196b miRNA inhibits the GATA6 intestinal transcription factor and is upregulated in colon cancer patients. Oncotarget. 2017;8(3):4747\u201359. https:\/\/doi.org\/10.18632\/oncotarget.13580.","journal-title":"Oncotarget."},{"issue":"2","key":"2245_CR15","first-page":"1862","volume":"8","author":"L Deng","year":"2015","unstructured":"Deng L, Liu H. MicroRNA-506 suppresses growth and metastasis of oral squamous cell carcinoma via targeting GATA6[J]. Int J Clin Exp Med. 2015;8(2):1862\u201370.","journal-title":"Int J Clin Exp Med"},{"key":"2245_CR16","first-page":"643","volume":"28","author":"W Yue","year":"2014","unstructured":"Yue W, Zhao R, Yu T. Expression and significance of dickkopf-1 and GATA-6 in laryngeal cancer. Clin Otolaryngol. 2014;28:643\u20136.","journal-title":"Clin Otolaryngol"},{"key":"2245_CR17","first-page":"1052","volume":"26","author":"Y Gao","year":"2008","unstructured":"Gao Y, Liu YW, Cao FC. Expression of nuclear transcription factor GATA6 in endometrial cancer and its relationship with prognosis. Chinese J Fam Plan. 2008;26:1052\u20135.","journal-title":"Chinese J Fam Plan"},{"issue":"S7","key":"2245_CR18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12864-016-2911-z","volume":"17","author":"G Jiang","year":"2016","unstructured":"Jiang G, Zhang S, Yazdanparast A, Li M, Pawar AV, Liu Y, et al. Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer. BMC Genomics. 2016;17(S7):525. https:\/\/doi.org\/10.1186\/s12864-016-2911-z.","journal-title":"BMC Genomics."},{"issue":"4","key":"2245_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/jop.12685","volume":"47","author":"H Sheng","year":"2018","unstructured":"Sheng H, Ogawa T, Niwano Y, Sasaki K, Tachibana K. Effects of polyphenols on doxorubicin-induced oral keratinocyte cytotoxicity and anticancer potency against oral cancer cells. J Oral Pathol Med. 2018;47(4):368\u201374. https:\/\/doi.org\/10.1111\/jop.12685.","journal-title":"J Oral Pathol Med."}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02245-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-021-02245-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-021-02245-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T22:02:51Z","timestamp":1621375371000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-021-02245-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2245"],"URL":"https:\/\/doi.org\/10.1186\/s12957-021-02245-y","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"22 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki (as was revised in 2013). The study was approved by the Ethics Committee of Union Hospital, Fujian Medical University, and informed consent was taken from all the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants signed a document of informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}